Agenus bio stock

The stock has a high of $2.60 for the year while the low is $0.79. The stock, however, witnessed a rise in its short on 01/31/20. Compared to previous close which recorded 3.93 M shorted shares, the short percentage went lower by -2.29%, as 3.84M AGEN shares were shorted. At the moment, only 3.79% of Sesen Bio Inc. shares were sold short.

Agenus Inc. Common Stock (AGEN) News Headlines | Nasdaq Find the latest news headlines from Agenus Inc. Common Stock (AGEN) at Nasdaq.com. Looking for additional market data? Visit old.nasdaq AMRX,BIO,AGEN,ABIO. May 9, 2019. Agenus Inc. Stock Price (AGEN) | Barron's Nov 08, 2019 · View today's stock price, news and analysis for Agenus Inc. (AGEN). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Agenus (AGEN) Stock Message Board - InvestorsHub Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the …

What are people saying about $AGEN?

AGEN is not discussed much on SI, and when it is it is just as likely to be mentioned on the biotech short thread as it is to be mentioned favorably. But some of  25 Jul 2018 Pre-Market Research Reports on Biotech Stocks -- Agenus, Aimmune Therapeutics, Akebia Therapeutics, and Alder Biopharma - read this  21 Sep 2018 Agenus has sold a portion of the royalties and milestones it is due to receive from Since peaking in March, Agenus' stock price has fallen by more than 60%. President Donald Trump gives a speech on HRAs · Biotech  7 Mar 2018 Steven Cohen Takes Stake in Biotech Company Agenus, Stocks: AGEN,REGN, MYL,MDT,VRTX,ABT, Steven Cohen, release date:Mar 07, 

Security and exchange commission filings for Agenus Inc. Insider trades, Agenus Inc is an American biotechnology company. Stock Style, Small Growth.

Stock Information – Agenus Stock information for Agenus, Inc. (AGEN) Call us with questions or submit a partner request. Historical Stock Price – Agenus Historical Stock Price. Select the date below to view the historical closing price for that particular day. The closing price is not indicative of future price performance. Historical Stock Prices are provided for informational purposes only and are not intended for trading purposes. Agenus Inc. (AGEN) Stock Price, Quote, History & News ... Find the latest Agenus Inc. (AGEN) stock quote, history, news and other vital information to help you with your stock trading and investing.

AGEN Stock Price, Forecast & News (Agenus) | MarketBeat

Agenus Inc. - AGEN - Stock Price Today - Zacks View Agenus Inc. AGEN investment & stock information. Get the latest Agenus Inc. AGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Agenus Inc. (AGEN) Latest Stock News & Headlines - Yahoo ... Get the latest Agenus Inc. (AGEN) stock news and headlines to help you in your trading and investing decisions. Agenus Inc. Common Stock (AGEN) Financials | Nasdaq Find the latest Financials data for Agenus Inc. Common Stock (AGEN) at Nasdaq.com.

Company profile for Agenus Inc (AGEN) including business summary, key statistics, ratios, sector. Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. A stock's Profile page contains

23 Oct 2017 Jim Cramer sat down with Garo Armen, the CEO of small-cap biotech Agenus, to speak about his company's pipeline and cell therapies. The Right Combination - Agenus Agenus Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update March 12, 2020 First QS-21 Royalty Payment Due to Agenus is Triggered March 10, 2020 To Cure Cancers Stock Information – Agenus Stock information for Agenus, Inc. (AGEN) Call us with questions or submit a partner request.

Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com and our twitter handle @agenus_bio. Information that may be important to investors will be routinely Agenus | LinkedIn